Félix Alegre

Clinica Universidad de Navarra — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index1.1kcitations56works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Porphyrin Metabolism and Disorders(9), COVID-19 Clinical Research Studies(8), Neonatal Health and Biochemistry(7), Hepatocellular Carcinoma Treatment and Prognosis(6), Sepsis Diagnosis and Treatment(6)

Publications56 total

Hypovitaminosis C in the context of the COVID-19 pandemic
Medicina Clínica (English Edition)·2024
Hypovitaminosis C in the context of the COVID-19 pandemic
Medicina Clínica·2023
Segmental Arterial Mediolysis and Pheochromocytoma: A Case Report
Journal of Vascular and Interventional Radiology·2022
Association of matrix metalloproteinases with poor prognosis in hospitalized patients with COVID-19
Revista Sangre·2022
Long-Term Outcome of Critically Ill Advanced Cancer Patients Managed in an Intermediate Care Unit
Journal of Clinical Medicine·2022· 1 citedOpen Access
Hypovitaminosis C as an unexpected cause of bleeding in a cirrhotic patient
Medicina Clínica (English Edition)·2022
Asociación de las metaloproteasas de matriz con el pronóstico en pacientes hospitalizados por COVID-19
Revista Sangre·2022Open Access
Hypovitaminosis C as an unexpected cause of bleeding in a cirrhotic patient
Medicina Clínica·2022
Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial
Thrombosis and Haemostasis·2021· 81 cited
Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients
Frontiers in Immunology·2021· 32 citedOpen Access
Large-scale silane bead-based SARS-CoV-2 testing of a nursing home in Spain identifies a viral reservoir during lockdown period
2021Open Access
Acquiring sepsis competencies through simulation-based learning bundle during intermediate care unit internship
Medicine·2021· 4 citedOpen Access
Immunologic characterization of COVID-19 patients with hematological cancer
Haematologica·2020· 16 citedOpen Access
Immunologic Characterization of Coronavirus Disease 2019 (COVID-19) Patients with Hematological Cancer: Biologic and Clinical Significance
Blood·2020Open Access
Immunophenotyping for Risk Stratification of Patients with COVID-19
SSRN Electronic Journal·2020Open Access
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks
Hepatology·2019· 158 citedOpen Access
EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks (S27.003)
Neurology·2019
FRI-442-Acute hepatic porphyria disease manifestations and daily life impacts in EXPLORE international, prospective, natural history study
Journal of Hepatology·2019· 6 cited
FRI-440-Management of acute hepatic porphyria attacks in europe and united states: EXPLORE international, prospective, natural history study
Journal of Hepatology·2019
An Analysis of Healthcare Utilization and Costs Associated with Patients with Acute Hepatic Porphyrias (AHPS) with Recurrent Attacks in Explore: A Prospective, Multinational Natural History Study of Patients with AHP
Value in Health·2018· 8 cited
page 1 of 3Next →

Frequent Co-authors

Jorge Quiroga(21), Manuel F. Landecho(18), Juan Felipe Lucena(14), Bruno Sangro(11), Mercedes Iñarrairaegui(11), J.I. Herrero(9), Nerea Fernández-Ros(9), Ana Huerta(8), Jesús Prìeto(7), Delia D’Avola(7), Francisco Carmona-Torre(7), Laurent Gouya(6), Paolo Ventura(6), Manisha Balwani(6), D. Montgomery Bissell(6), Robert J. Desnick(6), Michael N. Badminton(6), Jerzy Windyga(6), Maria Domenica Cappellini(6), Eliane Sardh(6)